Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Author: JarrettRobin B, ThaseMichael E

Paper Details 
Original Abstract of the Article :
BACKGROUND: Major Depressive Disorder (MDD) is highly prevalent and associated with disability and chronicity. Although cognitive therapy (CT) is an effective short-term treatment for MDD, a significant proportion of responders subsequently suffer relapses or recurrences. PURPOSE: This design prosp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/20451668

データ提供:米国国立医学図書館(NLM)

Cognitive Therapy for Preventing Recurrent Depression: A Double-Blind, Randomized Trial

This study, like a team of scientists carefully conducting an experiment, aims to determine the long-term effectiveness of cognitive therapy (CT) in preventing recurrent depression. The researchers, like skilled navigators charting a course through a complex and often turbulent sea of emotions, carefully designed a double-blind, randomized trial to compare the effectiveness of CT with fluoxetine, a common antidepressant. The study's findings, like a lighthouse guiding ships through a storm, offer compelling evidence that continuation phase CT can be a valuable tool for preventing recurrent depression, particularly in individuals who are at higher risk for relapse.

The Durability of Cognitive Therapy for Depression

This study, like a seasoned sailor navigating a treacherous ocean, explores the long-term impact of cognitive therapy (CT) on depression. The study found that individuals who received continuation phase CT after initial successful treatment were less likely to experience a relapse or recurrence of depression compared to those who received fluoxetine. This suggests that CT, like a sturdy ship that can withstand the storms, can offer a lasting benefit for those struggling with depression. The study's findings are like a treasure map, guiding us towards a more effective and sustainable approach to depression management.

A Hopeful Journey for Those Struggling with Depression

This study, like a beacon of hope in the darkness, offers a hopeful message for those struggling with depression. The findings suggest that CT, much like a seasoned traveler equipped with a compass and map, can help individuals navigate the challenging terrain of depression and find a path towards lasting recovery. This study is a valuable contribution to the understanding of depression and the potential of cognitive therapy to help individuals achieve long-term remission.

Dr. Camel's Conclusion

This study, like a desert caravan traveling through a vast and unforgiving landscape, provides evidence that cognitive therapy can be a valuable tool for preventing recurrent depression, offering a path towards lasting recovery.
Date :
  1. Date Completed 2011-03-16
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

20451668

DOI: Digital Object Identifier

NIHMS216278

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.